{"id":"W4388893508","doi":"10.1111/all.15952","title":"Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis and comorbid allergies","year":2023,"lang":"en","type":"article","venue":"Allergy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Pfizer","keywords":"Medicine; Atopic dermatitis; SCORAD; Comorbidity; Placebo; Asthma; Eczema Area and Severity Index; Dermatology Life Quality Index; Adverse effect; Allergy; Dermatology; Internal medicine; Quality of life (healthcare); Immunology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000262047,0.00009143651,0.0002370749,0.00009805358,0.00003703883,0.000005235697,0.00003338755,0.00005139974,0.00003652416],"category_scores_gemma":[0.00004084402,0.0000754248,0.00001264487,0.0001362149,0.00007905215,0.00004859067,0.00005116358,0.00005649765,0.000007548534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006131847,"about_ca_system_score_gemma":0.00002418959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000245446,"about_ca_topic_score_gemma":0.00006595352,"domain_scores_codex":[0.9994105,0.00002640947,0.0001635292,0.0001481814,0.000106253,0.0001451553],"domain_scores_gemma":[0.999642,0.00008216596,0.00003030512,0.0001169203,0.00003919641,0.00008946411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001410553,0.0002128794,0.984467,0.0002313623,0.0002175111,0.0001299938,0.001161599,0.0001831276,0.000008592466,0.000690643,0.008376363,0.002910378],"study_design_scores_gemma":[0.005449773,0.0001025362,0.990945,0.0001664712,0.00001174123,0.00001600735,0.00006702417,0.00009440199,0.00003987666,0.0001173617,0.002908221,0.00008151829],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977691,0.0002302037,0.000006485718,0.0007243817,0.0000213054,0.0002215563,0.00001433091,0.00003291782,0.0009797191],"genre_scores_gemma":[0.9988828,0.0002942678,0.0001024286,0.0004895938,0.00000648744,0.0000121116,0.00006582626,0.00001014748,0.0001362891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006478069,"threshold_uncertainty_score":0.3075734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008535983521442967,"score_gpt":0.2388859951072276,"score_spread":0.2303500115857846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}